Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineages dissemination in Brazil in 2023

Author:

Arantes IghorORCID,Gomes MarceloORCID,Ito Kimihito,Sarafim Sharbilla,Miyajima Fábio,Khouri Ricardo,Gräf Tiago,Siqueira Marilda Mendonça,Resende Paola CristinaORCID,Naveca Felipe GomesORCID,Bello GonzaloORCID,

Abstract

ABSTRACTThe SARS-CoV-2 XBB is a group of highly immune-evasive lineages of the Omicron VOC that emerged by recombining BA.2-descendent lineages and spread worldwide during 2023. In this study, we combine SARS-CoV-2 genomic data (n =11,065 sequences) with epidemiological data of Severe Acute Respiratory Infection (SARI) cases collected in Brazil between October 2022 and July 2023 to reconstruct the space-time dynamics and epidemiologic impact of XBB dissemination in the country. Our analyses revealed that the introduction and local emergence of lineages carrying convergent mutations within the Spike protein, especially F486P, F456L, and L455F, propelled the spread of XBB* lineages in Brazil. The average relative instantaneous reproduction numbers of XBB*+F486P, XBB*+F486P+F456L, and XBB*+F486P+ F456L+L455F lineages in Brazil were estimated to be 1.24, 1.33, and 1.48 higher than that of other co-circulating lineages (mainly BQ.1*/BE*), respectively. Despite such a growth advantage, the dissemination of these XBB* lineages had a reduced impact on Brazil’s epidemiological scenario concerning previous Omicron subvariants. The peak number of SARI cases from SARS-CoV-2 during the XBB wave was approximately 90%, 80%, and 70% lower than that observed during the previous BA.1*, BA.5*, and BQ.1* waves, respectively. These findings revealed the emergence of multiple XBB lineages with progressively increasing growth advantage, yet with relatively limited epidemiological impact in Brazil throughout 2023. The XBB*+F486P+F456L+L455F lineages stand out for their heightened transmissibility, warranting close monitoring in the months ahead.

Publisher

Cold Spring Harbor Laboratory

Reference74 articles.

1. Convergent evolution in sars-cov-2 spike creates a variant soup from which new COVID-19 waves emerge;International Journal of Molecular Sciences,2023

2. Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 – the public health challenges;International Journal of Infectious Diseases,2023

3. Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?;Singapore Medical Journal,2023

4. Characteristics of the omicron XBB subvariant wave in Singapore;The Lancet,2023

5. Tamura T , Ito J , Uriu K , Zahradnik J , Kida I , Anraku Y , Nasser H , Shofa M , Oda Y , Lytras S , Nao N , Itakura Y , Deguchi S , Suzuki R , Wang L , Begum MM , Kita S , Yajima H , Sasaki J , Sasaki-Tabata K , Shimizu R , Tsuda M , Kosugi Y , Fujita S , Pan L , Sauter D , Yoshimatsu K , Suzuki S , Asakura H , Nagashima M , Sadamasu K , Yoshimura K , Yamamoto Y , Nagamoto T , Schreiber G , Maenaka K , Ito H , Misawa N , Kimura I , Suganami M , Chiba M , Yoshimura R , Yasuda K , Iida K , Ohsumi N , Strange AP , Takahashi O , Ichihara K , Shibatani Y , Nishiuchi T , Kato M , Ferdous Z , Mouri H , Shishido K , Sawa H , Hashimoto R , Watanabe Y , Sakamoto A , Yasuhara N , Suzuki T , Kimura K , Nakajima Y , Nakagawa S , Wu J , Shirakawa K , Takaori-Kondo A , Nagata K , Kazuma Y , Nomura R , Horisawa Y , Tashiro Y , Kawai Y , Irie T , Kawabata R , Motozono C , Toyoda M , Ueno T , Hashiguchi T , Ikeda T , Fukuhara T , Saito A , Tanaka S , Matsuno K , Takayama K , Sato K . 2023. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nature Communications 14.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3